CIK 0000078003
- Large accelerated filer
PFIZER INC
Sign in to watch- Ticker
- PFE
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 135315170
- Phone
- +1 212-733-2323
- Business address
- 66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10001-2192
- Former names
- PFIZER INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-12 | Dolsten Mikael President R&D | Returned to the company · Stock Appreciation Rights | −137,760 | 0 | ||
| 2024-09-12 | Dolsten Mikael President R&D | Grant or award · Stock Appreciation Rights | +137,760 | 137,760 | ||
| 2024-09-12 | Dolsten Mikael President R&D | Returned to the company · Stock Appreciation Rights | −126,794 | 0 | ||
| 2024-09-12 | Dolsten Mikael President R&D | Grant or award · Stock Appreciation Rights | +126,794 | 126,794 | ||
| 2024-02-28 | Dolsten Mikael President R&D | Shares withheld for taxes | −21,437 | $27.04 | $580K | 321,729 |
| 2024-02-27 | Dolsten Mikael President R&D | Grant or award · Stock Appreciation Rights | +214,880 | 214,880 | ||
| 2024-02-27 | Dolsten Mikael President R&D | Grant or award · Stock Appreciation Rights | +189,867 | 189,867 | ||
| 2024-02-23 | Dolsten Mikael President R&D | Shares withheld for taxes | −24,822 | $27.76 | $689K | 343,166 |
Page 1 of 1 · 8 trades